2020 Annual Meeting | N3 - Neuroscience in the Clinic: Melatonin and Disrupted Sleep in Neurologic Disorders

Date Tuesday 04/28/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Temitayo Oyegbile-Chidi, MD, PhD, FAAN, Amy Gelfand, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Upon completion, participants should be familiar with sleep abnormalities observed in multiple neurologic disorders and how melatonin may affect neurologic function.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Event Timeline
03:30 PM - 03:40 PM	Introduction	General Overview: Specific Neurologic Disorders and Disrupted Sleep: Highlighting the Role of Melatonin Temitayo Oyegbile-Chidi, MD, PhD, FAAN
03:40 PM - 03:50 PM	Speaker	Clinical Vignette: Sleep Disruption and Migraine Amy Gelfand, MD
03:50 PM - 04:20 PM	Speaker	Sleep, Clocks, and Melatonin in Neurologic Disorders Aleksandar Videnovic, MD, MSc, FAAN
04:20 PM - 04:35 PM	Abstract	001 - A Computational Model of the Role of Melatonin in the Pathogenesis and Disrupted Sleep in Multiple Sclerosis João Marcos Brandet
04:35 PM - 04:50 PM	Abstract	002 - Peak Seizure Frequency Correlates with Disruptive Spiking in Rapid Eye Movement Sleep Marcus Ng, MD
04:50 PM - 05:05 PM	Speaker	Strategies to Modulate Melatonin to Affect Sleep Temitayo Oyegbile-Chidi, MD, PhD, FAAN
05:05 PM - 05:15 PM	Speaker	Clinical Vignette Wrap Up Amy Gelfand, MD
05:15 PM - 05:30 PM	Discussion	Panel Discussion

Faculty Disclosures
Temitayo Oyegbile-Chidi, MD, PhD, FAAN	Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum/The Transmitter. The institution of Dr. Oyegbile-Chidi has received research support from NIH.
Amy Gelfand, MD	An immediate family member of Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Headache Society. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of an immediate family member of Dr. Gelfand has received research support from Hoffman LaRoche. The institution of an immediate family member of Dr. Gelfand has received research support from Vigil Neuroscience. The institution of an immediate family member of Dr. Gelfand has received research support from NIH/NINDS. The institution of Dr. Gelfand has received research support from PCORI. The institution of Dr. Gelfand has received research support from UCSF RAP grant. Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Weill Cornell Neurology Department. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Taiwan Headache Society. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Author with Elsevier. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with College Board SSD. Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Speaker with Kobenhavns Unversitet. An immediate family member of Dr. Gelfand has a non-compensated relationship as a Clinical Trial Steering Committee Member with Roche/Genentech that is relevant to AAN interests or activities.
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has nothing to disclose.
Marcus Ng, MD	The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Michelle Lee Jones, MD	No disclosure on file
Marna McKenzie	No disclosure on file
	No disclosure on file
João Marcos Brandet	Mr. Brandet has nothing to disclose.
Aoife M. O'Carroll, MD	No disclosure on file

��ɫ��

��ɫ��